Twenty-four (19.5%) patients had DM2 which was controlled with diet in 18 patients and with insulin in six, whereas 50 (40.7%) patients had hypertension which was treated with angiotensin 2 receptor blockers in 42 and with ACE inhibitors in 8. The gene discussed is AGTR2; the disease is myotonic dystrophy type 2.